Home > Newsletters > FDAnews Drug Daily Bulletin > Lawmakers, Watchdogs Turn Up Heat on FDA After Reports of Further Email Monitoring
FDAnews Drug Daily Bulletin
July 19, 2012 | Vol. 9 No. 141
Lawmakers, Watchdogs Turn Up Heat on FDA After Reports of Further Email Monitoring
Lawmakers and watchdog groups are putting a brighter spotlight on the FDA, demanding the agency, HHS and White House take action to ensure whistleblower protections and investigate allegations of inappropriate email monitoring by the drug regulator. Sen. Chuck Grassley (R-Iowa) and others are questioning the FDA’s motives for dodging congressional inquiries and accusing it of trying to squash whistleblower protections.
Drug Industry Daily
ePublishing :: CMS, Hosting & Web Development | © Copyright by FDAnewsAll rights reserved. Do not duplicate or redistribute in any form.